10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0001564590-22-028583 |
| Period End Date | 20220630 |
| Filing Date | 20220809 |
| Fiscal Year | 2023 |
| Fiscal Period | Q1 |
| XBRL Instance | tyme-10q_20220630_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
66 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$13.74M | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$6.42M | USD | Point-in-time |
| Marketable securities |
MarketableSecuritiesCurrent
|
$60.61M | USD | Point-in-time |
| Marketable securities |
MarketableSecuritiesCurrent
|
$70.69M | USD | Point-in-time |
| Prepaid clinical costs |
PrepaidClinicalCostsCurrent
|
$431.48K | USD | Point-in-time |
| Prepaid clinical costs |
PrepaidClinicalCostsCurrent
|
$480.62K | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$4.06M | USD | Point-in-time |
| Prepaid expenses and other current assets |
PrepaidExpenseAndOtherAssetsCurrent
|
$1.48M | USD | Point-in-time |
| Preferred stock, par value (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$78.90M | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$79.02M | USD | Point-in-time |
| Preferred stock, par value (in dollars per share) |
PreferredStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Preferred stock, authorized |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Preferred stock, authorized |
PreferredStockSharesAuthorized
|
10.00M | shares | Point-in-time |
| Operating lease right-of-use asset |
OperatingLeaseRightOfUseAsset
|
$38.23K | USD | Point-in-time |
| Operating lease right-of-use asset |
OperatingLeaseRightOfUseAsset
|
$28.21K | USD | Point-in-time |
| Preferred stock, issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Preferred stock, issued |
PreferredStockSharesIssued
|
0.00 | shares | Point-in-time |
| Marketable securities |
MarketableSecuritiesNoncurrent
|
$1.11M | USD | Point-in-time |
| Marketable securities |
MarketableSecuritiesNoncurrent
|
$9.08M | USD | Point-in-time |
| Total assets |
Assets
|
$88.02M | USD | Point-in-time |
| Preferred stock, outstanding |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Total assets |
Assets
|
$80.16M | USD | Point-in-time |
| Preferred stock, outstanding |
PreferredStockSharesOutstanding
|
0.00 | shares | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, par value (in dollars per share) |
CommonStockParOrStatedValuePerShare
|
$0.00 | USD | Point-in-time |
| Common stock, authorized |
CommonStockSharesAuthorized
|
300.00M | shares | Point-in-time |
| Common stock, authorized |
CommonStockSharesAuthorized
|
300.00M | shares | Point-in-time |
| Accounts payable and other current liabilities (including $0 and $153,000 of related party accounts payable, respectively) |
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
$3.80M | USD | Point-in-time |
| Common stock, issued |
CommonStockSharesIssued
|
172.21M | shares | Point-in-time |
| Accounts payable and other current liabilities (including $0 and $153,000 of related party accounts payable, respectively) |
AccountsPayableAndOtherAccruedLiabilitiesCurrent
|
$4.69M | USD | Point-in-time |
| Common stock, issued |
CommonStockSharesIssued
|
172.21M | shares | Point-in-time |
| Severance payable |
SeverancePayableCurrent
|
$444.47K | USD | Point-in-time |
| Common stock, outstanding |
CommonStockSharesOutstanding
|
172.21M | shares | Point-in-time |
| Severance payable |
SeverancePayableCurrent
|
$2.61M | USD | Point-in-time |
| Common stock, outstanding |
CommonStockSharesOutstanding
|
172.21M | shares | Point-in-time |
| Accrued bonuses |
EmployeeRelatedLiabilitiesCurrent
|
$465.13K | USD | Point-in-time |
| Accrued bonuses |
EmployeeRelatedLiabilitiesCurrent
|
$933.08K | USD | Point-in-time |
| Operating lease liability |
OperatingLeaseLiabilityCurrent
|
$37.33K | USD | Point-in-time |
| Operating lease liability |
OperatingLeaseLiabilityCurrent
|
$26.49K | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$7.39M | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$5.62M | USD | Point-in-time |
| Severance payable, net of current portion |
SeverancePayableNoncurrent
|
$311.37K | USD | Point-in-time |
| Severance payable, net of current portion |
SeverancePayableNoncurrent
|
$421.57K | USD | Point-in-time |
| Warrant liability |
WarrantLiabilityNoncurrent
|
$124.48K | USD | Point-in-time |
| Warrant liability |
WarrantLiabilityNoncurrent
|
$89.56K | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$7.93M | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$6.02M | USD | Point-in-time |
| Commitments and contingencies (see Note 9) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and contingencies (see Note 9) |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding |
PreferredStockValue
|
- | USD | Point-in-time |
| Common stock, $0.0001 par value, 300,000,000 shares authorized, 172,206,894 issued and outstanding at June 30, 2022, 300,000,000 authorized, 172,206,894 issued and outstanding at March 31, 2022 |
CommonStockValue
|
$17.22K | USD | Point-in-time |
| Common stock, $0.0001 par value, 300,000,000 shares authorized, 172,206,894 issued and outstanding at June 30, 2022, 300,000,000 authorized, 172,206,894 issued and outstanding at March 31, 2022 |
CommonStockValue
|
$17.22K | USD | Point-in-time |
| Additional paid in capital |
AdditionalPaidInCapitalCommonStock
|
$241.57M | USD | Point-in-time |
| Additional paid in capital |
AdditionalPaidInCapitalCommonStock
|
$241.03M | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-544.26K | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-533.76K | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-160.42M | USD | Point-in-time |
| Accumulated deficit |
RetainedEarningsAccumulatedDeficit
|
$-166.91M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$101.80M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$80.08M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$74.14M | USD | Point-in-time |
| Total stockholders' equity |
StockholdersEquity
|
$96.48M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$80.16M | USD | Point-in-time |
| Total liabilities and stockholders' equity |
LiabilitiesAndStockholdersEquity
|
$88.02M | USD | Point-in-time |
Income Statement
36 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Revenues |
RevenueFromContractWithCustomerExcludingAssessedTax
|
- | USD | 1 Quarter |
| Related party legal expenses |
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
- | USD | 1 Quarter |
| Related party legal expenses |
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
|
$115.00K | USD | 1 Quarter |
| Revenues |
RevenueFromContractWithCustomerExcludingAssessedTax
|
- | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpense
|
$4.18M | USD | 1 Quarter |
| Research and development |
ResearchAndDevelopmentExpense
|
$1.96M | USD | 1 Quarter |
| General and administrative (including $0 and $115,000 of related party legal expenses, respectively) |
GeneralAndAdministrativeExpense
|
$2.47M | USD | 1 Quarter |
| General and administrative (including $0 and $115,000 of related party legal expenses, respectively) |
GeneralAndAdministrativeExpense
|
$4.65M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$6.65M | USD | 1 Quarter |
| Total operating expenses |
OperatingExpenses
|
$6.61M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-6.65M | USD | 1 Quarter |
| Loss from operations |
OperatingIncomeLoss
|
$-6.61M | USD | 1 Quarter |
| Change in fair value of warrant liability |
FairValueAdjustmentOfWarrants
|
$-34.92K | USD | 1 Quarter |
| Change in fair value of warrant liability |
FairValueAdjustmentOfWarrants
|
$-725.14K | USD | 1 Quarter |
| Other income |
OtherNonoperatingIncome
|
$89.41K | USD | 1 Quarter |
| Other income |
OtherNonoperatingIncome
|
$19.52K | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$11.87K | USD | 1 Quarter |
| Interest expense |
InterestExpense
|
$21.26K | USD | 1 Quarter |
| Total other income (expense) |
NonoperatingIncomeExpense
|
$112.46K | USD | 1 Quarter |
| Total other income (expense) |
NonoperatingIncomeExpense
|
$723.41K | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-6.49M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-5.93M | USD | 1 Quarter |
| Basic loss per common share |
EarningsPerShareBasic
|
$-0.04 | USD | 1 Quarter |
| Basic loss per common share |
EarningsPerShareBasic
|
$-0.03 | USD | 1 Quarter |
| Diluted loss per common share |
EarningsPerShareDiluted
|
$-0.04 | USD | 1 Quarter |
| Diluted loss per common share |
EarningsPerShareDiluted
|
$-0.03 | USD | 1 Quarter |
| Basic weighted average shares outstanding |
WeightedAverageNumberOfSharesOutstandingBasic
|
172.21M | shares | 1 Quarter |
| Basic weighted average shares outstanding |
WeightedAverageNumberOfSharesOutstandingBasic
|
172.21M | shares | 1 Quarter |
| Diluted weighted average shares outstanding |
WeightedAverageNumberOfDilutedSharesOutstanding
|
172.21M | shares | 1 Quarter |
| Diluted weighted average shares outstanding |
WeightedAverageNumberOfDilutedSharesOutstanding
|
172.21M | shares | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-6.49M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-5.93M | USD | 1 Quarter |
| Unrealized gain (loss) on marketable securities, net of tax |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
$-33.84K | USD | 1 Quarter |
| Unrealized gain (loss) on marketable securities, net of tax |
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
|
$10.50K | USD | 1 Quarter |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-5.96M | USD | 1 Quarter |
| Comprehensive loss |
ComprehensiveIncomeNetOfTax
|
$-6.48M | USD | 1 Quarter |
Cash Flow Statement
43 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net loss |
ProfitLoss
|
$-5.93M | USD | 1 Quarter |
| Net loss |
ProfitLoss
|
$-6.49M | USD | 1 Quarter |
| Amortization of employees, directors and consultants stock options |
ShareBasedCompensation
|
$540.47K | USD | 1 Quarter |
| Amortization of employees, directors and consultants stock options |
ShareBasedCompensation
|
$643.66K | USD | 1 Quarter |
| Change in fair value of warrant liability |
FairValueAdjustmentOfWarrants
|
$-34.92K | USD | 1 Quarter |
| Change in fair value of warrant liability |
FairValueAdjustmentOfWarrants
|
$-725.14K | USD | 1 Quarter |
| Net amortization of premiums and discounts on marketable securities |
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
$-227.30K | USD | 1 Quarter |
| Net amortization of premiums and discounts on marketable securities |
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
$-389.12K | USD | 1 Quarter |
| Prepaid clinical costs |
IncreaseDecreaseInPrepaidClinicalCosts
|
$-905.30K | USD | 1 Quarter |
| Prepaid clinical costs |
IncreaseDecreaseInPrepaidClinicalCosts
|
$-49.15K | USD | 1 Quarter |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-2.63M | USD | 1 Quarter |
| Prepaid expenses and other assets |
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
$-186.63K | USD | 1 Quarter |
| Operating lease right-of-use asset |
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
|
$-8.91K | USD | 1 Quarter |
| Operating lease right-of-use asset |
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
|
$-10.02K | USD | 1 Quarter |
| Accounts payable and other current liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$-280.96K | USD | 1 Quarter |
| Accounts payable and other current liabilities |
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
$881.79K | USD | 1 Quarter |
| Severance payable |
IncreaseDecreaseInSeverancePayable
|
$-2.28M | USD | 1 Quarter |
| Severance payable |
IncreaseDecreaseInSeverancePayable
|
$-168.00K | USD | 1 Quarter |
| Accrued bonuses |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$-670.11K | USD | 1 Quarter |
| Accrued bonuses |
IncreaseDecreaseInEmployeeRelatedLiabilities
|
$-467.95K | USD | 1 Quarter |
| Operating lease liability |
IncreaseDecreaseInOperatingLeaseLiabilities
|
$-10.84K | USD | 1 Quarter |
| Operating lease liability |
IncreaseDecreaseInOperatingLeaseLiabilities
|
$-7.78K | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-4.78M | USD | 1 Quarter |
| Net cash used in operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$-5.81M | USD | 1 Quarter |
| Purchases of marketable securities |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$65.25M | USD | 1 Quarter |
| Purchases of marketable securities |
PaymentsToAcquireAvailableForSaleSecuritiesDebt
|
$17.02M | USD | 1 Quarter |
| Proceeds from maturities of marketable securities |
ProceedsFromSaleAndMaturityOfMarketableSecurities
|
$14.48M | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-65.25M | USD | 1 Quarter |
| Net cash used in investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-2.54M | USD | 1 Quarter |
| Proceeds from exercise of stock options |
ProceedsFromStockOptionsExercised
|
$6.19K | USD | 1 Quarter |
| Net cash provided by financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$6.19K | USD | 1 Quarter |
| Net decrease in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-71.06M | USD | 1 Quarter |
| Net decrease in cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-7.32M | USD | 1 Quarter |
| Cash and cash equivalents beginning |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$107.52M | USD | Point-in-time |
| Cash and cash equivalents beginning |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$36.46M | USD | Point-in-time |
| Cash and cash equivalents beginning |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$13.74M | USD | Point-in-time |
| Cash and cash equivalents beginning |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$6.42M | USD | Point-in-time |
| Cash and cash equivalents ending |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$107.52M | USD | Point-in-time |
| Cash and cash equivalents ending |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$36.46M | USD | Point-in-time |
| Cash and cash equivalents ending |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$13.74M | USD | Point-in-time |
| Cash and cash equivalents ending |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
$6.42M | USD | Point-in-time |
| Interest |
InterestPaidNet
|
$21.26K | USD | 1 Quarter |
| Interest |
InterestPaidNet
|
$11.87K | USD | 1 Quarter |
Stockholders Equity
19 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Balance, at beginning |
StockholdersEquity
|
$101.80M | USD | Point-in-time |
| Balance, at beginning |
StockholdersEquity
|
$80.08M | USD | Point-in-time |
| Balance, at beginning |
StockholdersEquity
|
$74.14M | USD | Point-in-time |
| Balance, at beginning |
StockholdersEquity
|
$96.48M | USD | Point-in-time |
| Balance, at beginning (in shares) |
CommonStockSharesOutstanding
|
172.21M | shares | Point-in-time |
| Balance, at beginning (in shares) |
CommonStockSharesOutstanding
|
172.21M | shares | Point-in-time |
| Proceeds from the exercise of stock options |
StockIssuedDuringPeriodValueStockOptionsExercised
|
$6.19K | USD | 1 Quarter |
| Stock based compensation |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$643.66K | USD | 1 Quarter |
| Stock based compensation |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$540.47K | USD | 1 Quarter |
| Unrealized gain (loss) on available-for-sale securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$10.50K | USD | 1 Quarter |
| Unrealized gain (loss) on available-for-sale securities |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
$-33.84K | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-6.49M | USD | 1 Quarter |
| Net loss |
NetIncomeLoss
|
$-5.93M | USD | 1 Quarter |
| Balance, at end |
StockholdersEquity
|
$101.80M | USD | Point-in-time |
| Balance, at end |
StockholdersEquity
|
$80.08M | USD | Point-in-time |
| Balance, at end |
StockholdersEquity
|
$74.14M | USD | Point-in-time |
| Balance, at end |
StockholdersEquity
|
$96.48M | USD | Point-in-time |
| Balance, at end (in shares) |
CommonStockSharesOutstanding
|
172.21M | shares | Point-in-time |
| Balance, at end (in shares) |
CommonStockSharesOutstanding
|
172.21M | shares | Point-in-time |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.